Andrew Davenport
Overview
Explore the profile of Andrew Davenport including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
514
Citations
6572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Battaglia Y, Shroff R, Meijers B, Nistor I, Alfano G, Franssen C, et al.
Nephrol Dial Transplant
. 2025 Feb;
PMID: 39914451
Haemodialysis (HD) is a life-saving therapy for individuals with kidney failure. Post-filter haemodiafiltration (HDF) and high-flux HD are the most widely used treatment modalities. To date, five randomised controlled trials...
2.
Schouten A, Fischer F, Blankestijn P, Vernooij R, Hockham C, Strippoli G, et al.
Kidney Int
. 2025 Jan;
PMID: 39848405
High-flux hemodialysis (HD) and high-dose hemodiafiltration (HDF) are established treatments for patients with kidney failure. Since HDF has been associated with improved survival rates compared to HD, we evaluated the...
3.
Nguyen M, Davenport A
J Hum Nutr Diet
. 2024 Dec;
38(1).
PMID: 39687979
Introduction: Increasing numbers of elderly co-morbid patients with end-stage kidney disease (ESKD) are now offered haemodialysis. Simple, rapid screening tools are required to risk-assess patients, highlighting those requiring nutritional or...
4.
Johal N, Sharma R, Belcher J, Coyle D, Lindley E, Keane D, et al.
BMC Nephrol
. 2024 Nov;
25(1):398.
PMID: 39506729
Introduction: Fluid assessment and management is a key aspect of good dialysis care and is affected by patient-level characteristics and potentially centre-level practices. In this secondary analysis of the BISTRO...
5.
Vernooij R, Hockham C, Strippoli G, Green S, Hegbrant J, Davenport A, et al.
Lancet
. 2024 Nov;
PMID: 39489903
Background: High-dose haemodiafiltration has been shown, in a randomised clinical trial, to result in a 23% lower risk of mortality for patients with kidney failure when compared with conventional high-flux...
6.
Wanner C, Vanholder R, Ortiz A, Davenport A, Canaud B, Blankestijn P, et al.
Front Nephrol
. 2024 Oct;
4:1455260.
PMID: 39473870
Purpose Of Symposium: From September 6 - 8 2022, the Life/2022 Membrane Symposium was held in Frankfurt, Germany, and transmitted live to a worldwide internet audience. The event was part...
7.
Belcher J, Coyle D, Lindley E, Keane D, Caskey F, Dasgupta I, et al.
Kidney360
. 2024 Oct;
PMID: 39388617
Background: Preservation of residual kidney function (RKF) in dialysis patients has been associated with improved survival. RKF in the BISTRO trial was relatively well preserved and here we describe its...
8.
Jaques D, Chhabra R, Khatri P, Davenport A
Artif Organs
. 2024 Oct;
49(2):300-309.
PMID: 39377155
Introduction: Hyperkalemia is frequently encountered and associated with cardio-vascular mortality in chronic hemodialysis (HD) patients. While online hemodiafiltration (OL-HDF) is thought to offer clinical benefit over high-flux HD, the impact...
9.
Burke L, Bernal W, Pirani T, Agarwal B, Jalan R, Ryan J, et al.
J Hepatol
. 2024 Oct;
PMID: 39362282
Background & Aims: Therapeutic plasma exchange (PEX) has emerged as a potential treatment option for patients with acute liver failure (ALF). The effect of PEX on survival outcomes outside of...
10.
Cromm K, Ngoc Pham L, Jaha H, Fischer K, Liegl G, Schappert A, et al.
Kidney360
. 2024 Oct;
PMID: 39356555
Background: We investigated whether psychosocial determinants self-efficacy and social support are associated with Health-Related Quality of Life in hemodialysis patients enrolled in the CONVINCE trial. Methods: We used baseline data...